https://www.selleckchem.com/products/myci361.html
To understand timing of complete polypoidal regression on indocyanine green angiography (ICGA) after aflibercept injections in polypoidal choroidal vasculopathy (PCV). Multicenter prospective study PARTICIPANTS Adults with treatment-naïve PCV METHODS After IRB approval, participants were enrolled and followed for 1 year, Apr 1, 2016 to Dec 30, 2018 at two university-based centers in Thailand. PCV diagnosis was based on the EVEREST criteria. Eligible eyes received fixed-dosing aflibercept injections (3 monthly then every-8-week), or mont
Gefällt mir
Kommentar
Teilen
